Results 81 to 90 of about 133,774 (116)
An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy.
Angewandte Chemie, 2017 Nikki A. Thiele +15 more
semanticscholar +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Lancet Oncology, The
BACKGROUND Actinium-225 (225Ac) prostate-specific membrane antigen (PSMA) radioligand therapy (RLT) is a novel therapy for metastatic castration-resistant prostate cancer (mCRPC). We aimed to report the safety and antitumour activity of 225Ac-PSMA RLT of
Clemens Kratochwil +2 more
exaly +2 more sources
BACKGROUND Actinium-225 (225Ac) prostate-specific membrane antigen (PSMA) radioligand therapy (RLT) is a novel therapy for metastatic castration-resistant prostate cancer (mCRPC). We aimed to report the safety and antitumour activity of 225Ac-PSMA RLT of
Clemens Kratochwil +2 more
exaly +2 more sources
Chemical Biology and Drug Design, 2023
In nuclear medicine, cancers that cannot be cured or can only be treated partially by traditional techniques like surgery or chemotherapy are killed by ionizing radiation as a form of therapeutic treatment.
Maria Hassan +4 more
semanticscholar +1 more source
In nuclear medicine, cancers that cannot be cured or can only be treated partially by traditional techniques like surgery or chemotherapy are killed by ionizing radiation as a form of therapeutic treatment.
Maria Hassan +4 more
semanticscholar +1 more source
Chemical Reviews, 2023
Molecular changes in malignant tissue can lead to an increase in the expression levels of various proteins or receptors that can be used to target the disease.
Katherine A Morgan +3 more
semanticscholar +1 more source
Molecular changes in malignant tissue can lead to an increase in the expression levels of various proteins or receptors that can be used to target the disease.
Katherine A Morgan +3 more
semanticscholar +1 more source
Optical Fiber Communications Conference and Exhibition, 2023
Both 5-km and 10-km transmission was demonstrated under 225-Gb/s PAM4 operation using EA-DFB lasers. We confirmed low TDECQ values of 2.0~3.2 dB for 5 km in the CWDM range and 10 km at 1293.5 nm.
Kazuki Nishimura +9 more
semanticscholar +1 more source
Both 5-km and 10-km transmission was demonstrated under 225-Gb/s PAM4 operation using EA-DFB lasers. We confirmed low TDECQ values of 2.0~3.2 dB for 5 km in the CWDM range and 10 km at 1293.5 nm.
Kazuki Nishimura +9 more
semanticscholar +1 more source
Journal of the American Chemical Society, 2022
We report a nonadentate bispidine (3,7-diazabicyclo[3.3.1]nonane) that unveils the potential to bind theranostically relevant radionuclides, including indium-111, lutetium-177, and actinium-225 under mild labeling conditions.
P. Cieslik +11 more
semanticscholar +1 more source
We report a nonadentate bispidine (3,7-diazabicyclo[3.3.1]nonane) that unveils the potential to bind theranostically relevant radionuclides, including indium-111, lutetium-177, and actinium-225 under mild labeling conditions.
P. Cieslik +11 more
semanticscholar +1 more source
Challenges and opportunities in developing Actinium-225 radiopharmaceuticals
Nuclear medicine communications, 2022Actinium-225 (225Ac) has emerged as a promising therapeutic radioisotope for targeted alpha therapy. It emits net four alpha particles during its decay to stable daughter bismuth-209, rightly called an in-vivo nano-generator.
D. Dhiman, Rakhee Vatsa, A. Sood
semanticscholar +1 more source